Using LabPiQture to uncover or disprove chronic kidney disease
About 35.5 million people in the United States are currently affected by chronic kidney disease (CKD), and the prevalence of ensuing kidney failure is rising.1 ExamOne was asked how insurers can quickly and confidently determine if their applicant has kidney disease. In a recent case study, we show how eGFR results highlighted in LabPiQture TM uncover or disprove chronic kidney disease.
What is eGFR?
- According to the National Kidney Foundation, Glomerular filtration rate (GFR) is the best overall index of kidney function. 2
- Healthcare providers use estimated glomerular filtration rate (eGFR) to determine kidney disease, and if so, what stage.
- The standard way to estimate eGFR is with a simple blood test.
What value do eGFR results bring to an underwriter?
- The underwriter will look for the stability or conversely the instability of the eGFR to make a possible risk assessment decision.
How would an underwriter access this data?
- eGFR results will be highlighted in laboratory testing results provided through ExamOne’s LabPiQture.
See eGFR results in action through LabPiQture.
Learn more about how LabPiQture provides critical information regarding CKD and tremendous insights into an applicant’s health profile.
About LabPiQture
Through LabPiQture insurers have access to an extensive clinical laboratory database which includes physician-ordered laboratory testing results related to preventative care, disease monitoring, and diagnostic purposes. LabPiQture has become an integral part of many underwriting decisions. In addition to clinical laboratory results, detailed information such as diagnosis codes, LOINC codes and ordering physician information has proven valuable. Reinsurers have been actively engaged in studying subsets of deidentified LabPiQture data to evaluate the effectiveness of this unique information source.
Read more studies here.
1Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023 (cdc.gov)
